NCT03939702View on ClinicalTrials.gov

Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

July 11, 2019

Study Completion Date

July 11, 2019

Conditions
Thrombosis
Interventions
DRUG

BMS-986177

An orally administered anticoagulant to prevent and treat thromboembolic events

Trial Locations (1)

53704

Covance Clinical Research Unit, Inc., Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03939702 - Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants | Biotech Hunter | Biotech Hunter